Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug:158:104903.
doi: 10.1016/j.phrs.2020.104903. Epub 2020 May 13.

Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter's and Gitelman's syndrome patients

Lorenzo A Calò  1 , Giovanni Bertoldi  2 , Paul A Davis  3
Affiliations
Comment

Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter's and Gitelman's syndrome patients

Lorenzo A Calò et al. Pharmacol Res. 2020 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

None
Graphical abstract
See this image and copyright information in PMC

Comment on

References

    1. Abedi F., Hayes A.W., Reiter R., Karimi G. Acute Lung Injury: the therapeutic role of Rho kinase inhibitors. Pharmacol. Res. 2020 - PubMed
    1. Abedi F., Rezaee R., Karimi G. Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19) Pharmacol. Res. 2020;156 - PMC - PubMed
    1. Calò L.A., Davis P.A., Rossi G.P. Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter’s and Gitelman’s syndromes, human models of endogenous angiotensin II signaling antagonism. J. Hypertens. 2014;32:2109–2119. - PubMed
    1. Seccia T.M., Rigato M., Ravarotto V., Calò L.A. ROCK (RhoA/Rho kinase) in cardiovascular-renal pathophysiology: a review of new advancements. J. Clin. Med. 2020;9:1328. doi: 10.3390/jcm9051328. - DOI - PMC - PubMed
    1. Calò L.A., Schiavo S., Davis P.A., Pagnin E., Mormino P., D’Angelo A., Pessina A.C. ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications. J. Nephrol. 2010;23:472–477. - PubMed

Substances